WO2001012851A3 - Identification of genetic markers of biological age and metabolism - Google Patents

Identification of genetic markers of biological age and metabolism Download PDF

Info

Publication number
WO2001012851A3
WO2001012851A3 PCT/US2000/021603 US0021603W WO0112851A3 WO 2001012851 A3 WO2001012851 A3 WO 2001012851A3 US 0021603 W US0021603 W US 0021603W WO 0112851 A3 WO0112851 A3 WO 0112851A3
Authority
WO
WIPO (PCT)
Prior art keywords
organ
tissue
cell
subject
gene expression
Prior art date
Application number
PCT/US2000/021603
Other languages
French (fr)
Other versions
WO2001012851A2 (en
Inventor
Richard H Weindruch
Tomas A Prolla
Cheol-Koo Lee
Original Assignee
Wisconsin Alumni Res Found
Weindruch, Richard, H.
Prolla, Tomas, A.
Cheol-Koo Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found, Weindruch, Richard, H., Prolla, Tomas, A., Cheol-Koo Lee filed Critical Wisconsin Alumni Res Found
Priority to AU65289/00A priority Critical patent/AU782102B2/en
Priority to EP00952626A priority patent/EP1200629B1/en
Priority to CA2381777A priority patent/CA2381777C/en
Priority to DE60037817T priority patent/DE60037817D1/en
Publication of WO2001012851A2 publication Critical patent/WO2001012851A2/en
Publication of WO2001012851A3 publication Critical patent/WO2001012851A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Abstract

A method of measuring the biological age of a multicellular organism is disclosed. In one embodiment this method comprises the steps of obtaining a sample of nucleic acid isolated from the organism's organ, tissue or cell and determining the expression pattern of a panel of sequences within the nucleic acid that have been predetermined by either increase or decrease in response to biological aging of the organ, tissue or cell. A method of obtaining biomarkers of aging is also disclosed. This method comprises the step of comparing a gene expression profile of a young multicellular organism subject's organ, tissue or cells; a gene expression profile from a chronologically aged subject's organ, tissue or cell; and a gene expression profile from a chronologically aged but biologically younger subject's organ, tissue or cell and identifying gene expression alterations that are observed when comparing the young subjects and the chronologically aged subjects and are not observed or reduced in magnitude when comparing the young subject and the chronologically aged but biologically younger subjects.
PCT/US2000/021603 1999-08-12 2000-08-08 Identification of genetic markers of biological age and metabolism WO2001012851A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU65289/00A AU782102B2 (en) 1999-08-12 2000-08-08 Identification of genetic markers of biological age and metabolism
EP00952626A EP1200629B1 (en) 1999-08-12 2000-08-08 Identification of genetic markers of biological age and metabolism
CA2381777A CA2381777C (en) 1999-08-12 2000-08-08 Identification of genetic markers of biological age and metabolism
DE60037817T DE60037817D1 (en) 1999-08-12 2000-08-08 IDENTIFICATION OF GENETIC MARKERS OF BIOLOGICAL AGE AND METABOLISM

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US14854099P 1999-08-12 1999-08-12
US60/148,540 1999-08-12
US17823200P 2000-01-26 2000-01-26
US60/178,232 2000-01-26
US21192300P 2000-06-16 2000-06-16
US60/211,923 2000-06-16

Publications (2)

Publication Number Publication Date
WO2001012851A2 WO2001012851A2 (en) 2001-02-22
WO2001012851A3 true WO2001012851A3 (en) 2001-08-23

Family

ID=27386702

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/021603 WO2001012851A2 (en) 1999-08-12 2000-08-08 Identification of genetic markers of biological age and metabolism

Country Status (7)

Country Link
US (3) US6569624B1 (en)
EP (1) EP1200629B1 (en)
AT (1) ATE384137T1 (en)
AU (1) AU782102B2 (en)
CA (1) CA2381777C (en)
DE (1) DE60037817D1 (en)
WO (1) WO2001012851A2 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US7452664B2 (en) 1999-12-15 2008-11-18 Massachusetts Institute Of Technology Methods for identifying agents which alter histone protein acetylation
US8642284B1 (en) 1999-12-15 2014-02-04 Massachusetts Institute Of Technology Methods for identifying agents that alter NAD-dependent deacetylation activity of a SIR2 protein
US6406853B1 (en) 1999-12-23 2002-06-18 The Regents Of The University Of California Interventions to mimic the effects of calorie restriction
WO2001045752A1 (en) * 1999-12-23 2001-06-28 The Regents Of The University Of California Interventions to mimic the effects of calorie restriction
WO2002059310A2 (en) 2000-12-12 2002-08-01 University Of Connecticut Polynucleotides encoding cellular transporters and methods of use thereof
US7572575B2 (en) 2000-12-13 2009-08-11 Massachusetts Institute Of Technology SIR2 activity
US7041449B2 (en) * 2001-03-19 2006-05-09 Wisconsin Alumni Research Foundation Methods of screening for compounds that inhibit expression of biomarker sequences differentially expressed with age in mice
CA2451247A1 (en) 2001-06-22 2003-01-03 The Regents Of The University Of California Eukaryotic genes involved in adult lifespan regulation
US20030036079A1 (en) * 2001-06-26 2003-02-20 Weindruch Richard H. Gene expression alterations underlying the retardation of aging by caloric restriction in mammals
AU2002313737A1 (en) * 2001-08-13 2003-04-01 University Of Kentucky Research Foundation Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment
WO2003016573A1 (en) * 2001-08-15 2003-02-27 Elixir Pharmaceuticals, Inc. Age-associated markers
KR20040064275A (en) 2001-11-09 2004-07-16 소스 프리시전 메디슨, 인코포레이티드 Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
WO2003099781A2 (en) * 2002-05-24 2003-12-04 Boehringer Ingelheim Pharmaceuticals, Inc. METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
CA2494066A1 (en) * 2002-08-09 2004-02-19 Cynthia Kenyon Eukaryotic genes involved in adult lifespan regulation
FR2847269B1 (en) * 2002-11-19 2006-07-28 Coletica METHOD FOR IDENTIFYING AN EVENTUAL MODIFICATION OF AT LEAST ONE BIOLOGICAL PARAMETER USING YOUNG AND AGE LIVING CELLS
EP2308968A1 (en) * 2002-11-26 2011-04-13 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US20040191775A1 (en) * 2003-03-12 2004-09-30 Spindler Stephen R. Methods of analyzing genes affected by caloric restriction or caloric restriction mimetics
WO2005042795A2 (en) * 2003-10-31 2005-05-12 Queststar Medical, Inc. Plasma polymerization of atomically modified surfaces
US20070275108A1 (en) * 2003-12-19 2007-11-29 Geesamen Bard J Life Span Managment
WO2005089436A2 (en) * 2004-03-16 2005-09-29 The Regents Of The University Of California Genetic networks regulated by attenuated gh/igf1 signaling and caloric restriction
US20050228237A1 (en) * 2004-04-12 2005-10-13 Frank Shallenberger Method for analyzing the biological age of a subject
US7273453B2 (en) * 2004-04-12 2007-09-25 Frank Shallenberger Method for analyzing the biological age of a subject
WO2005123955A2 (en) * 2004-06-09 2005-12-29 Children's Medical Center Corporation Methods and compositions for modifying gene regulation and dna damage in ageing
EP1854510B1 (en) * 2005-02-15 2012-04-04 Yugenkaisha Japan Tsusyo Physical strength age measuring method
US20070099830A1 (en) 2005-04-21 2007-05-03 Massachusetts Institute Of Technology Sirt4 activities
US7960605B2 (en) * 2006-03-17 2011-06-14 BioMaker Pharmaceuticals, Inc. Methods for testing for caloric restriction (CR) mimetics
EP2813580A1 (en) * 2006-10-13 2014-12-17 Metabolon, Inc. Biomarkers related to metabolic age and methods using the same
WO2008102038A2 (en) * 2007-02-23 2008-08-28 Progenika Biopharma, S.A. Method and product for 'in vitro' genotyping with applications in anti-ageing medicine
US8420088B2 (en) 2008-01-28 2013-04-16 Novartis Ag Methods and compositions using FGF23 fusion polypeptides
US7666137B2 (en) * 2008-04-10 2010-02-23 Frank Shallenberger Method for analyzing mitochondrial function
AU2009246180B2 (en) 2008-05-14 2015-11-05 Dermtech International Diagnosis of melanoma and solar lentigo by nucleic acid analysis
CA2734521A1 (en) * 2008-08-28 2010-03-04 Dermtech International Determining age ranges of skin samples
US20120040855A1 (en) * 2009-03-11 2012-02-16 Yuanlong Pan Tissue-specific aging biomarkers
US20110091081A1 (en) * 2009-10-16 2011-04-21 General Electric Company Method and system for analyzing the expression of biomarkers in cells in situ in their tissue of origin
US8320655B2 (en) * 2009-10-16 2012-11-27 General Electric Company Process and system for analyzing the expression of biomarkers in cells
US8824769B2 (en) * 2009-10-16 2014-09-02 General Electric Company Process and system for analyzing the expression of biomarkers in a cell
BR112012011133A2 (en) * 2009-11-10 2016-07-05 Nestec Sa cardiac aging biomarkers and methods of use
KR101993009B1 (en) 2010-05-24 2019-06-25 엔에스이 프로덕츠, 인크. Oral formulations for counteracting effects of aging
WO2013027191A1 (en) 2011-08-25 2013-02-28 Novartis Ag Methods and compositions using fgf23 fusion polypeptides
US8652518B2 (en) 2012-04-15 2014-02-18 Jahahreeh Finley Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
FR2993282B1 (en) * 2012-07-13 2017-11-10 Expanscience Lab METHOD FOR IDENTIFYING MOLECULAR MARKERS OF CHILD'S SKIN
US20190093163A1 (en) * 2015-06-12 2019-03-28 President And Fellows Of Harvard College Compositions and methods for maintaining splicing fidelity
US20190078162A1 (en) * 2017-09-14 2019-03-14 OneSkin Technologies, Inc. In vitro methods for skin therapeutic compound discovery using skin age biomarkers
US11578373B2 (en) 2019-03-26 2023-02-14 Dermtech, Inc. Gene classifiers and uses thereof in skin cancers
US11227691B2 (en) 2019-09-03 2022-01-18 Kpn Innovations, Llc Systems and methods for selecting an intervention based on effective age
US11250337B2 (en) 2019-11-04 2022-02-15 Kpn Innovations Llc Systems and methods for classifying media according to user negative propensities

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013610A2 (en) * 1994-10-31 1996-05-09 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087102A (en) * 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6406853B1 (en) 1999-12-23 2002-06-18 The Regents Of The University Of California Interventions to mimic the effects of calorie restriction

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013610A2 (en) * 1994-10-31 1996-05-09 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BANDANA CHATTERJEE ET AL.: "Differential regulation of the messenger RNA for three major senescence marker proteins in male rat liver", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 256, no. 12, 25 June 1981 (1981-06-25), pages 5939 - 5941, XP000990218 *
CHEOL-KOO LEE ET AL.: "Gene expression profile of aging and its retardation by caloric restriction", SCIENCE, vol. 285, no. 5432, 27 August 1999 (1999-08-27), DC, pages 1390 - 1393, XP002162927 *
CHEOL-KOO LEE ET AL.: "Gene-expression profile of the ageing brain in mice", NATURE GENETICS, vol. 25, no. 3, July 2000 (2000-07-01), pages 294 - 297, XP000990091 *
CHERYL WISTROM ET AL.: "Cloning and expression of SAG: A novel marker of cellular senescence", EXPERIMENTAL CELL RESEARCH, vol. 199, no. 2, April 1992 (1992-04-01), pages 355 - 362, XP000099098 *
MALCOLM H. GOYNS ET AL.: "Differential display analysis of gene expression indicates that age-related changes are restricted to a small cohort of genes", MECHANISMS OF AGEING AND DEVELOPMENT, vol. 101, no. 1,2, 16 March 1998 (1998-03-16), pages 73 - 90, XP000990037 *
MARIA TRESINI ET AL.: "Effects of donor age on the expression of a marker of replicative senescence (EPC-1) in human dermal fibroblasts", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 179, April 1999 (1999-04-01), pages 11 - 17, XP000990062 *
ROY L. WALFORD ET AL.: "Dietary restriction and aging: historical phases, mechanisms and current directions", JOURNAL OF NUTRITION, vol. 117, no. 10, October 1987 (1987-10-01), pages 1650 - 1654, XP000990310 *

Also Published As

Publication number Publication date
WO2001012851A2 (en) 2001-02-22
AU6528900A (en) 2001-03-13
AU782102B2 (en) 2005-07-07
US6569624B1 (en) 2003-05-27
ATE384137T1 (en) 2008-02-15
DE60037817D1 (en) 2008-03-06
US20030157526A1 (en) 2003-08-21
EP1200629B1 (en) 2008-01-16
CA2381777A1 (en) 2001-02-22
EP1200629A2 (en) 2002-05-02
CA2381777C (en) 2011-10-04
US20080254464A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
WO2001012851A3 (en) Identification of genetic markers of biological age and metabolism
WO2002074911A3 (en) Identification of gene expression alterations underlying the aging process in mammals
DK0979308T3 (en) Procedure for Preparing a Diagnostic Standard Gene Transcript Pattern
WO2004105573A3 (en) Method of diagnosis of cancer based on gene expression profiles in cells
WO2001057273A3 (en) Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
US20020107640A1 (en) Methods for determining the true signal of an analyte
ATE253647T1 (en) METHOD AND COMPOSITION FOR DETECTING PATHOGENIC CONDITIONS
EP1170380A3 (en) Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
EP2612927A3 (en) Markers for prenatal diagnosis and monitoring
WO2004046687A3 (en) Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates
Goedde et al. Population genetic and family studies on aldehyde dehydrogenase deficiency and alcohol sensitivity
EP1085098A3 (en) A composition for providing long term stability to cells for diagnostic testing
JP2001524311A5 (en)
GB2366378A (en) Genetic marker test for lupus
WO2000070340A3 (en) Materials and methods relating to disease diagnosis
WO2003002712A3 (en) Gene expression alterations underlying the retardation of aging by caloric restriction in mammals
WO2001062965A3 (en) Differential expression screening method
ATE279535T1 (en) ANALYSIS METHOD FOR DETERMINING A PATIENT'S PREDIPOSITION TO AT LEAST ONE DISEASE AND SUITABLE AMPLIFICATION FOR SUCH A METHOD
EP3415635A1 (en) Age determination of a human individual
WO2005060656A3 (en) Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy
WO1999006831A3 (en) Breast cancer resistance genes, methods for their detection and uses thereof
WO2000058521A3 (en) Methods for the identification of reporter and target molecules using comprehensive gene expression profiles
EP1106683A3 (en) A method for providing long term stability to cells for diagnostic testing
Price What's in a name (or a number or a date)?
Qin et al. Genotyping the–6A/G functional polymorphism in the core promoter region of angiotensinogen gene by microchip electrophoresis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 65289/00

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2000952626

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2381777

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 2000952626

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWG Wipo information: grant in national office

Ref document number: 65289/00

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2000952626

Country of ref document: EP